Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Solanezumab> ?p ?o. }
Showing items 1 to 55 of
55
with 100 items per page.
- Solanezumab abstract "Solanezumab (proposed INN) is a monoclonal antibody being investigated by Eli Lilly as a neuroprotector for patients with Alzheimer's disease.It binds to the amyloid-β peptides that make up the protein plaques seen in the brains of people with the disease.2012 results of the EXPEDITION 1 & 2 phase 3 clinical trials were only mildly encouraging. but were said to be the "first evidence that targeting the amyloid cascade can slow the progression of disease.”".
- Solanezumab atcPrefix "none".
- Solanezumab casNumber "955085-14-0".
- Solanezumab fdaUniiCode "5D6PWO0333".
- Solanezumab wikiPageID "21198129".
- Solanezumab wikiPageRevisionID "589783675".
- Solanezumab atcPrefix "none".
- Solanezumab c "6396".
- Solanezumab casNumber "955085".
- Solanezumab chemspiderid "NA".
- Solanezumab h "9922".
- Solanezumab hasPhotoCollection Solanezumab.
- Solanezumab kegg "D10058".
- Solanezumab legalStatus "Investigational".
- Solanezumab mabType "mab".
- Solanezumab molecularWeight "144.1".
- Solanezumab n "1712".
- Solanezumab o "1996".
- Solanezumab s "42".
- Solanezumab source "zu".
- Solanezumab target Beta_amyloid.
- Solanezumab type "mab".
- Solanezumab unii "5".
- Solanezumab verifiedfields "changed".
- Solanezumab verifiedrevid "464404831".
- Solanezumab subject Category:Monoclonal_antibodies.
- Solanezumab type Abstraction100002137.
- Solanezumab type Antibody115027189.
- Solanezumab type Chemical114806838.
- Solanezumab type Compound114818238.
- Solanezumab type Macromolecule114944888.
- Solanezumab type Material114580897.
- Solanezumab type Matter100020827.
- Solanezumab type Molecule114682133.
- Solanezumab type MonoclonalAntibodies.
- Solanezumab type MonoclonalAntibody115029781.
- Solanezumab type OrganicCompound114727670.
- Solanezumab type Part113809207.
- Solanezumab type PhysicalEntity100001930.
- Solanezumab type Protein114728724.
- Solanezumab type Relation100031921.
- Solanezumab type Substance100019613.
- Solanezumab type Thing100002452.
- Solanezumab type Unit109465459.
- Solanezumab type Drug.
- Solanezumab type DrugProduct.
- Solanezumab type FunctionalSubstance.
- Solanezumab comment "Solanezumab (proposed INN) is a monoclonal antibody being investigated by Eli Lilly as a neuroprotector for patients with Alzheimer's disease.It binds to the amyloid-β peptides that make up the protein plaques seen in the brains of people with the disease.2012 results of the EXPEDITION 1 & 2 phase 3 clinical trials were only mildly encouraging. but were said to be the "first evidence that targeting the amyloid cascade can slow the progression of disease.”".
- Solanezumab label "Solanezumab".
- Solanezumab sameAs m.05c3gbk.
- Solanezumab sameAs Q7555695.
- Solanezumab sameAs Q7555695.
- Solanezumab sameAs Solanezumab.
- Solanezumab wasDerivedFrom Solanezumab?oldid=589783675.
- Solanezumab isPrimaryTopicOf Solanezumab.